Matthew Wilson

February 9, 2023

American Society for Clinical Investigation honors 10 Vanderbilt physicians

By Bill Snyder

May 2, 2019

Wilson appointed to ASGCT board of directors

The American Society of Gene and Cell Therapy (ASGCT) has appointed Matthew Wilson, MD, PhD, associate professor of Medicine in Vanderbilt’s Division of Nephrology and Hypertension, to its board of directors. Beginning in May 2019, Wilson will serve a three-year term as an at-large director.

By Kelsey Herbers

March 14, 2019

Reprogramming cells for kidney repair

Using gene transfer technologies to reprogram adult human kidney cells could lead to novel therapies for chronic kidney disease.

By Kelsey Herbers

April 10, 2018

Vanderbilt scientists test potential new way to treat anemia

Treatment of anemia caused by chronic kidney disease or other diseases often requires repeated — and costly — injections or infusions of an artificial form of the hormone erythropoietin (EPO), which stimulates production of red blood cells.

By Bill Snyder